EQT Private Equity to sell Igenomix to Vitrolife for an enterprise value of EUR 1.25 billion
The combination of Igenomix and Vitrolife will make a global leader in reproductive health by combining the knowledge, product portfolios ...
Read more
The combination of Igenomix and Vitrolife will make a global leader in reproductive health by combining the knowledge, product portfolios ...
Read more